Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer

NCT00003243 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Leukemia
Lymphoma
Myelodysplastic Syndromes
Myelodysplastic/Myeloproliferative Diseases

Interventions

BIOLOGICAL: aldesleukin
BIOLOGICAL: filgrastim
BIOLOGICAL: therapeutic allogeneic lymphocytes
DRUG: cyclophosphamide
DRUG: etoposide
DRUG: pegylated liposomal doxorubicin hydrochloride

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]